Vaxart announces publication of phase 1 results of oral norovirus tablet vaccine
Vaxart announced publication of the comprehensive results of the previously disclosed Phase 1 clinical trial with its norovirus oral tablet vaccine in the Journal of Clinical Investigation Insight. The primary immunological endpoint of the study, an increase in BT50 titers, was met. July 12, 2018